Turkey’s shock central bank swap, Covid-era drug shortages, Goldman Sachs enforced weekend rule
Investor confidence in Turkey is shaken by the shock dismissal of the head of the central bank and the appointment of a new central banker with unorthodox ideas on how to tackle the country’s economic challenges, the increased production of the Covid-19 vaccine is creating shortages of other medicines, and Goldman Sachs bows to workplace complaints by junior bankers.
Turkey’s lira tumbles after Erdogan sacks central bank chief
Push to make Covid vaccines causes US drug shortages
David Solomon commits to Saturdays off for Goldman Sachs bankers
See acast.com/privacy for privacy and opt-out information.
A transcript for this podcast is currently unavailable, view our accessibility guide.
Get alerts on FT News Briefing when a new story is published